Table 1. Presentation features of... | American Society of Hematology

Table 1.

Presentation features of patients in Medical Research Council AML11

Parameter	Value	No. of patients			Percentage of patients^*
Parameter	Value	DAT	ADE	MAC	Percentage of patients^*
Age	< 56	6	5	9	2
	56-59	37	37	75	11
	60-64	92	95	186	28
	65-69	105	101	207	32
	70-74	69	65	137	21
	75-79	18	17	39	6
	80	1	3	3	1
Sex	Male	185	184	368	56
	Female	143	143	288	44
Type of AML	De novo	247	250	502	76
	Secondary	78	74	147	23
	Not AML	3	3	7	1
White blood count, × 10⁹/L	0-9	157	169	315	49
	10-99	136	118	241	38
	100-199	18	24	61	8
	200	10	10	22	3
	Unknown	7	6	17	3
FAB type	M0	13	13	25	4
	M1	76	81	166	25
	M2	83	86	174	26
	M3	15	14	30	5
	M4	56	55	93	15
	M5	32	24	56	9
	M6	8	12	26	4
	M7	5	3	10	1
	RAEB-T	3	2	5	1
	Unknown	37	37	71	11
Performance status	0	154	154	308	47
	1	120	120	241	37
	2	27	27	53	8
	3	23	21	43	7
	4	4	5	11	2
Cytogenetic group	Favorable	19	18	40	6
	Intermediate	215	216	419	65
	Adverse	39	35	71	11
	Unknown	55	58	126	18

Parameter	Value	No. of patients			Percentage of patients^*
Parameter	Value	DAT	ADE	MAC	Percentage of patients^*
Age	< 56	6	5	9	2
	56-59	37	37	75	11
	60-64	92	95	186	28
	65-69	105	101	207	32
	70-74	69	65	137	21
	75-79	18	17	39	6
	80	1	3	3	1
Sex	Male	185	184	368	56
	Female	143	143	288	44
Type of AML	De novo	247	250	502	76
	Secondary	78	74	147	23
	Not AML	3	3	7	1
White blood count, × 10⁹/L	0-9	157	169	315	49
	10-99	136	118	241	38
	100-199	18	24	61	8
	200	10	10	22	3
	Unknown	7	6	17	3
FAB type	M0	13	13	25	4
	M1	76	81	166	25
	M2	83	86	174	26
	M3	15	14	30	5
	M4	56	55	93	15
	M5	32	24	56	9
	M6	8	12	26	4
	M7	5	3	10	1
	RAEB-T	3	2	5	1
	Unknown	37	37	71	11
Performance status	0	154	154	308	47
	1	120	120	241	37
	2	27	27	53	8
	3	23	21	43	7
	4	4	5	11	2
Cytogenetic group	Favorable	19	18	40	6
	Intermediate	215	216	419	65
	Adverse	39	35	71	11
	Unknown	55	58	126	18

DAT indicates daunorubicin, cytarabine, and thioguanine; ADE, daunorubicin, cytarabine, and etoposide; MAC, mitoxantrone-cytarabine; AML, acute myeloid leukemia; FAB, French-American-British; RAEB-T, refractory anemia with excess blasts in transformation; ALL, acute lymphoblastic leukemia.

Percentages may not add up to 100 because of rounding.

View Large

This Feature Is Available To Subscribers Only